Glaxosmithkline | GSK - Loan Capital

Stock Price
50.26
Daily Change
-0.64 -1.26%
Monthly
-0.48%
Yearly
33.53%
Q2 Forecast
48.78

Glaxosmithkline reported GBP19.82B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bausch Health Companies USD 19.9B 720M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Canopy Growth CAD 224.99M 1.34M Dec/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.62B 17.5M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 1.01B 40.28M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Takeda JPY 4.37T 99.51B Mar/2026
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026
Zoetis USD 9.04B 3M Mar/2026